TACI Blocking Peptide

TACI Blocking Peptide

Product No.: T325

[product_table name="All Top" skus="T325"]

- -
- -
Target
Transmembrane Activator & Calcium Modulator and Cyclophilin Ligand
Product Type
Blocking Peptide
Alternate Names
TNFRSF13B, CD267, CVID, FLJ39942, MGC133214, MGC39952, TNFRSF14B

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 2 to 16 of Human TACI protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
Transmembrane activator & calcium modulator and cyclophilin ligand (CAML) interactor (TACI) is lymphocyte specific member1,2 of the tumor necrosis factor-receptor superfamily3 and is expressed in B-lymphocytes and may act to regulate humoral immunity.4 TACI also serves as a receptor for B-cell activating factor of the TNF family (BAFF) and as a proliferation-inducing ligand (APRIL).5

Antigen Details

References & Citations

1. Schwaller J et al. (2007) Blood 109: 331 2. Slazer U et al. (2005) Nat Genet. 37: 820 3. Bonilla FA et al. (2006) Curr Allergy Asthma Rep. 6: 357 4. Bram RJ et al. (2000) Mamm Genome. 11: 628 5. Kobata T et al. (2007) Blood 109: 2961
Products are for research use only. Not for use in diagnostic or therapeutic procedures.